HomeMEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES
The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.
This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.
1st U.S. Hospitals Implement The Sirius Pintuition System
The Sirius Pintuition System is CE marked and FDA 510(k) cleared and over 3,000 procedures have been performed worldwide.
Accuray and Limbus AI Inc. Partnership
Accuray and Limbus AI will enable Accuray to use Limbus' technology to streamline the treatment planning process and increase operational efficiency.
SPIRA-P and SPIRA-T Devices Enter Full National Launch Mode Reports Camber Spine
Camber Spine notes the complete portfolio for posterior approach exhibited and focus sessions to be presented at ISASS.
MedAlliance’s SELUTION SLR ™ Drug-eluting Balloon (DEB) Receives FDA Investigational Device Exemption (IDE) Approval
SELUTION SLR was also the first DEB granted “Breakthrough Device Designation” by the FDA on March 4, 2019 and further on September 25, 2019 for below-the-knee (BTK) indications in peripheral artery disease.
Vivo Surgical Announces Acceptance into Mount Sinai Innovation Partners’ Strategic Birtual Incubator – Elementa Labs
Elementa Labs is a strategic virtual incubator that positions healthcare and biotechnology start-ups for the next stage in their development states Vivo Surgical.
Conformis Highlights New Clinical Study Findings
The new study supports Conformis’ longtime assertion that knee joint replacements that are fully personalized to each patient’s unique anatomy may be best to limit post-surgical pain and optimize patient satisfaction
Centerline Biomedical Announces Successful Structural Heart Animal Study
As Centerline Biomedical grows the R&D pipeline for its novel 3D-GNC (guidance, navigation and control) technology, it has made structural heart disease a focus because of the limitations of x-ray fluoroscopy and the current need for multiple concomitant imaging modalities to complete certain procedures.
SurgiSTUD Launches a New Orthopedic Subdivision in their STUD Catalog
These STUDs are surgical training models with superior biomechanical fidelity, customizability, and cost savings over existing cadaveric and synthetic training options notes reports SurgiSTUD.
Exactech Announces FDA Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System
Exactech, a minority shareholder of JointMedica Limited, is collaborating with the United Kingdom-based orthopaedic device designer and manufacturer to deliver the next generation of hip resurfacing to the global market, and holds exclusive global distribution rights to the product.
